Evidence map›Paper›PMID 32257186›Full record

ArticleBiomedical reports2020

Immunological markers and

Jesús Guillermo Espinoza-Contreras, Miriam Idalia Torres-Ruiz, Luis Ariel Waller-González, José De Jesús Ramírez-García, Javier Torres-López, Javier Ventura-Juárez, Elizabeth Verónica Moreno-Córdova, Juan Ernesto López-Ramos, Martin Humberto Muñoz-Ortega, María Eugenia Vargas-Camaño and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedical reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jesús Guillermo Espinoza-ContrerasDepartamento de Microbiología, Universidad Autónoma de Aguascalientes, Aguascalientes Ags, CP 20131, México.
Miriam Idalia Torres-RuizDepartamento de Endoscopia, Centro Médico Nacional 20 de Noviembre ISSSTE, Ciudad de México, CP 03229, México.
Luis Ariel Waller-GonzálezDepartamento de Endoscopia, Centro Médico Nacional 20 de Noviembre ISSSTE, Ciudad de México, CP 03229, México.
José De Jesús Ramírez-GarcíaDepartamento de Endoscopia, Centro Médico Nacional 20 de Noviembre ISSSTE, Ciudad de México, CP 03229, México.
Javier Torres-LópezUnidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias UMAE, Hospital de Pediatría, IMSS, Ciudad de México, CP 06720, México.
Javier Ventura-JuárezDepartamento de Morfología, Universidad Autónoma de Aguascalientes, Aguascalientes Ags, CP 20131, México.
Elizabeth Verónica Moreno-CórdovaDepartamento de Microbiología, Universidad Autónoma de Aguascalientes, Aguascalientes Ags, CP 20131, México.
Juan Ernesto López-RamosDepartamento de Microbiología, Universidad Autónoma de Aguascalientes, Aguascalientes Ags, CP 20131, México.
Martin Humberto Muñoz-OrtegaDepartamento de Química, Universidad Autónoma de Aguascalientes, Aguascalientes Ags, CP 20131, México.
María Eugenia Vargas-CamañoServicio de Inmunología Clínica y Alergía, Centro Médico Nacional 20 Noviembre ISSSTE, Ciudad de México, CP 03229, México.
Rodolfo González-SegoviaDepartamento de Microbiología, Universidad Autónoma de Aguascalientes, Aguascalientes Ags, CP 20131, México.
Autonomous University of Aguascalientes · MXInstitute for Social Security and Services for State Workers · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Programmed death-ligand 1 (PD-L1) and ICOS-L (also referred to as B7 homolog 1 and 2, respectively) modulate the immune inflammatory response. The aim of the present study was to examine the expression levels of these inflammatory mediators in two groups of patients with an

Indexed as

gastric cancerHelicobacter pyloriICOS-LIL-17programmed death-ligand 1retinoid orphan receptor γtvacA-m1

Identifiers

PMID32257186
PMCPMC7100142
OpenAlexW3009121566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.